Cocrystal Pharma Inc (COCP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 51,108 | 54,839 | 58,755 | 61,694 | 67,112 |
| TOTAL | $51,596 | $55,399 | $59,323 | $62,441 | $67,337 |
| Non-Current Assets | |||||
| PPE Net | 363 | 407 | 453 | 493 | 539 |
| Intangibles | 0 | 19,092 | 19,092 | 19,092 | 19,092 |
| Other Non-Current Assets | 424 | 474 | 524 | 572 | 449 |
| TOTAL | $787 | $19,973 | $20,069 | $20,157 | $20,080 |
| Total Assets | $52,383 | $75,372 | $79,392 | $82,598 | $87,417 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,571 | 1,314 | 1,297 | 961 | 2,138 |
| Other current liabilities | N/A | 1 | 12 | 34 | 51 |
| TOTAL | $2,813 | $1,558 | $1,545 | $1,228 | $2,379 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 177 | 234 | 291 | 344 | 269 |
| TOTAL | $177 | $234 | $298 | $358 | $290 |
| Total Liabilities | $2,990 | $1,792 | $1,843 | $1,586 | $2,669 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 8,119 | 8,119 | 8,119 | 8,119 | 8,119 |
| Common Shares | 98 | 98 | 8 | 98 | 98 |
| Retained earnings | -287,729 | -263,301 | -259,093 | -255,408 | -251,467 |
| TOTAL | $49,393 | $73,580 | $77,549 | $81,012 | $84,748 |
| Total Liabilities And Equity | $52,383 | $75,372 | $79,392 | $82,598 | $87,417 |